항원 시장(2026-2030년)

The global antigen market is forecasted to grow by USD 694.6 mn during 2025-2030, accelerating at a CAGR of 8.1% during the forecast period. The report on the global antigen market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing global burden of infectious and chronic diseases, pivotal technological advancements in antigen production and design, heightened global focus on vaccine development and pandemic preparedness.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global antigen market is segmented as below:

By Type

• Viral antigens
• Bacterial antigens
• Others

By Application

• Medical diagnostic
• Vaccine development
• Others

By End-User

• Manufacturers
• Diagnostic centers
• Hospitals
• Research institutes

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the shifting role of antigens in era of nucleic acid platforms as one of the prime reasons driving the global antigen market growth during the next few years. Also, rise of personalized oncology and demand for neoantigens and expansion of multiplexing in diagnostics and point-of-care testing will lead to sizable demand in the market.

The report on the global antigen market covers the following areas:

• Global antigen market sizing
• Global antigen market forecast
• Global antigen market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global antigen market vendors that include Abcam plc, Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., BioMerieux SA, Creative Diagnostics, Danaher Corp., DiaSorin SpA, Fapon Biotech, GenScript Biotech Corp., Hologic Inc., ImmunoDX LLC, LGC Ltd., Merck KGaA, RayBiotech Life Inc., Sd Biosensor Inc., Siemens Healthineers AG, Sino Biological Inc., Sysmex Corp., Thermo Fisher Scientific Inc.. Also, the global antigen market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Antigen Market 2020 - 2024
  • Historic Market Size - Data Table on Global Antigen Market 2020 - 2024 ($ million)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Antigen Market
• 6.2 Impact of Geopolitical Conflicts on Global Antigen Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Viral antigens - Market size and forecast 2025-2030
• 8.4 Bacterial antigens - Market size and forecast 2025-2030
• 8.5 Others - Market size and forecast 2025-2030
• 8.6 Market opportunity by Type
  • Market opportunity by Type ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Medical diagnostic - Market size and forecast 2025-2030
• 9.4 Vaccine development - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Manufacturers - Market size and forecast 2025-2030
• 10.4 Diagnostic centers - Market size and forecast 2025-2030
• 10.5 Hospitals - Market size and forecast 2025-2030
• 10.6 Research institutes - Market size and forecast 2025-2030
• 10.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing global burden of infectious and chronic diseases
  • Pivotal technological advancements in antigen production and design
  • Heightened global focus on vaccine development and pandemic preparedness
• 13.2 Market challenges
  • Navigating complex and evolving regulatory frameworks
  • Overcoming technical complexity and ensuring batch-to-batch consistency
  • Managing intense price competition and market saturation in commoditized segments
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Shifting role of antigens in era of nucleic acid platforms
  • Rise of personalized oncology and demand for neoantigens
  • Expansion of multiplexing in diagnostics and point-of-care testing

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abcam plc
  • Abcam plc - Overview
  • Abcam plc - Product / Service
  • Abcam plc - Key offerings
  • SWOT
• 15.5 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.6 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.7 Bio Techne Corp.
  • Bio Techne Corp. - Overview
  • Bio Techne Corp. - Business segments
  • Bio Techne Corp. - Key offerings
  • Bio Techne Corp. - Segment focus
  • SWOT
• 15.8 Danaher Corp.
  • Danaher Corp. - Overview
  • Danaher Corp. - Business segments
  • Danaher Corp. - Key news
  • Danaher Corp. - Key offerings
  • Danaher Corp. - Segment focus
  • SWOT
• 15.9 Fapon Biotech
  • Fapon Biotech - Overview
  • Fapon Biotech - Product / Service
  • Fapon Biotech - Key offerings
  • SWOT
• 15.10 GenScript Biotech Corp.
  • GenScript Biotech Corp. - Overview
  • GenScript Biotech Corp. - Business segments
  • GenScript Biotech Corp. - Key offerings
  • GenScript Biotech Corp. - Segment focus
  • SWOT
• 15.11 Hologic Inc.
  • Hologic Inc. - Overview
  • Hologic Inc. - Product / Service
  • Hologic Inc. - Key offerings
  • SWOT
• 15.12 ImmunoDX LLC
  • ImmunoDX LLC - Overview
  • ImmunoDX LLC - Product / Service
  • ImmunoDX LLC - Key offerings
  • SWOT
• 15.13 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.14 RayBiotech Life Inc.
  • RayBiotech Life Inc. - Overview
  • RayBiotech Life Inc. - Product / Service
  • RayBiotech Life Inc. - Key offerings
  • SWOT
• 15.15 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.16 Sino Biological Inc.
  • Sino Biological Inc. - Overview
  • Sino Biological Inc. - Product / Service
  • Sino Biological Inc. - Key offerings
  • SWOT
• 15.17 Sysmex Corp.
  • Sysmex Corp. - Overview
  • Sysmex Corp. - Business segments
  • Sysmex Corp. - Key offerings
  • Sysmex Corp. - Segment focus
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations